Japan Generics Drug Market Sales Revenue Opportunity Report 2020

Japan is a small island nation located in East Asia and it is known for its economic prosperity. It sports one of the largest pharmaceutical markets like US and Europe due to which immense commercialization opportunities are present. Unique demographic structure and presence of advanced technology is the main reason for the growth of Japanese pharmaceutical industry. They have one of the most advanced research and development facilities across the world contributing significantly to the development of healthcare infrastructure. Japan has opened its pharmaceutical market for foreign trade leading to higher input of drugs. Their population is going in downward spiral where number of young people are lesser then geriatric population. In this way, they have high demand for therapeutic products due which their pharmaceutical market is increasing.

Download Report:

https://www.kuickresearch.com/report-Japan-Generics-Drug-Market-Outlook-2020.php

For Report Sample Contact: neeraj@kuickresearch.com or +91-11-47067990

"Japan Generics Drug Market Outlook 2020"Table of Contents

1. Introduction to Japan Generic Drug Market
1.1 Reasons for Growth of Japan Generic Market
1.2 Some Misconceptions Related to Generic Drugs in Japan

2. Attractiveness of Japan Generic Market
2.1 Overview of Japan Pharmaceutical Market
2.2 Features of Japan Generic Drugs Market
2.3 Generic Drug Firms in Japan
2.4 Generic Drugs Import in Japan
2.5 Economic Views about Generic Drugs

3. Scenario of Generic Drugs in Japan
3.1 Scenario for Generic Drug Discount Price in Japan
3.2 Different Categories of Pharmaceutical Patent in Japan
3.3 Promotion of Generic Drugs in Japan

4. Super Generics in Japan
4.1 Introduction to Super Generics
4.2 Advantages of Super Generics
4.3 Disadvantages of Super Generics

5. Different Parameters for Generic & Branded Drugs in Japan
5.1 Patent Protection in Japan
5.2 Effect on Japan Healthcare Spending
5.3 Japan Pharmacological Parameters for Generic Drugs
5.4 Difference in Regulatory Requirements
5.5 Utilization of Branded & Generic Drugs in Japan Market

6. Generic Active Pharmaceutical Ingredients in Japan
6.1 Generic Active Pharmaceutical Ingredient Registration
6.2 Regulation for Foreign Companies in Japan
6.3 Manufacturing Capabilities for Generic API

7. Health in Japan & Utilization of Generic Drugs
7.1 Cancer Incidences in Japan
7.2 Increasing Diabetes Incidences in Japan
7.3 Increasing Cerebrovascular Incidences in Japan
7.4 Cardiovascular Diseases Incidences in Japan
7.5 Disease Caused by Pollution in Japan

8. Healthcare System & Generic Drugs in Japan
8.1 Universal Healthcare Coverage
8.2 Price Rise Control
8.3 Quality Control of Generic Drugs
8.4 Access to Generic Market
8.5 Patents Related Issues to Generic Drugs in Japan
8.6 Factors Restricting Uptake of Generic Drugs in Japan

9. Comparison of Generic Drugs in US & Japan
9.1 Regulatory Framework for Generic Drugs
9.2 Market Penetration of Generic Drugs
9.3 Prices of Generic Drugs
9.4 Perception towards Generic Drugs

10. Japan Generic Drugs Market Analysis

11. Japan Generic Market Favorable Factors
11.1 Ageing Population
11.2 Generic Drugs Regulations
11.3 High Technological Capabilities
11.4 Increasing Disease Incidences

12. Japan Generics Market Commercialization Challenges
12.1 Japan Regulatory Environment
12.2 Attitude towards Generic Drugs
12.3 Lower uptake of Generic Drugs
12.4 Conflicting Patent Laws

13. Japan Generic Drugs Market Future Prospects

14. Competitive Landscape
14.1 Actavis
14.2 Eisai
14.3 Fuji Pharma
14.4 GlaxoSmithKline
14.5 Hospira
14.6 Meiji Seika Pharma
14.7 Nichi-Iko Pharmaceutical
14.8 Nipro Pharma
14.9 Pfizer
14.10 Sawai Pharmaceuticals
14.11 Takeda Pharmaceutical
14.12 Towa Pharmaceutical

Figure 1-1: Reasons for Growth of Japan Generic Market
Figure 1-2: Some Steps taken by Japan Regulators to Decrease Drug Prices
Figure 1-3: Some Misconceptions Related to Generic Drugs in Japan
Figure 2-1: Some Considerations while Approaching Japan Generic Market
Figure 3-1: Discount Determination of Generic Drugs in Japan
Figure 3-2: Type of Drug Price Survey in Japan
Figure 4-1: Advantages of Super Generics
Figure 4-2: Disadvantages of Super Generics
Figure 5-1: Economic Benefits of opting Generic Drugs
Figure 5-2: Regulatory Requirement for Generic Drugs in Japan
Figure 5-3: Utilization of Branded and Generic Drugs in Japan Market
Figure 6-1: Requirements for Registration of API
Figure 6-2: Regulation for Foreign Companies in Japan
Figure 6-3: Japan - Manufacturing Capabilities for Generic API
Figure 7-1: Aim of Basic Plan to Promote Cancer Control Programs
Figure 7-2: Estimated Numbers of Cancer Cases in Japan, 2015
Figure 8-1: Position of Generics in Japan Healthcare System
Figure 8-2: Patents Related Issues to Generic Drugs in Japan
Figure 10-1: Japan - Generics Drug Market (US$ & Yen), 2014-2016
Figure 10-2: Japan - Generics Drug Share in Pharmaceutical Market (%), 2014
Figure 11-1: Japan - Generic Drugs Market Drivers
Figure 12-1: Japan - Generics Market Commercialization Challenges
Figure 13-1: Japan - Generics Drug Market (US$ & Yen), 2017-2020
Figure 13-2: Japan - Generics Drug Share of Prescription Drug (%), 2018
Figure 13-3: Japan - Generics Drug Share of Prescription Drug (%), 2020
Figure 13-4: Japan - Generics Drug Share in Pharmaceutical Market (%), 2020

Table 1-1: Some Important Features of Japan
Table 3-1: Listing Period for Various Drugs in Japan
Table 5-1: Difference between Branded and Generic Drugs in Japan
Table 5-2: Regulatory Requirements for Different Drugs in Japan
Table 7-1: Estimated Numbers of Different Cancer Affecting Japan Population, 2015
Table 7-2: Estimated Numbers of Males Affected by Different Type of Cancer in Japan, 2015
Table 7-3: Estimated Numbers of Females Affected by Different Type of Cancer in Japan, 2015
Table 7-4: Issues related with Cerebrovascular Diseases
Table 7-5: Some Important Diseases caused by Pollutants in Japan
Table 9-1: Difference in Regulatory Framework between Japan & US

Kuick Research is a market research and analytics company that provides targeted information for critical decisions at business, product and service levels. We are quick, predictive and known by the recommendations we have made in the past. Our result-oriented research methodology offers understanding of multiple issues in a short period of time and gives us the capability to keep you full with loads of practical ideas. By translating research answers into strategic insight and direction, we not only rate the success potential of your products and/or services, but also help you identify the opportunities for growth in new demographies and find ways to beat competition.

Neeraj Chawla
neeraj@kuickresearch.com
KuicK Research
Avanta Business Center 4th Floor,
Statesman House Barakhamba Road,
Connaught Place New Delhi – 110 001, India

This release was published on openPR.